Dáil Éireann Debate, Wednesday - 24 November 2021
164. Deputy Colm Burke asked the Minister for Health the reason the review of the governance structures regarding the HSE drug reimbursement process by a company (details supplied) still remains under consideration by his Department despite being submitted to his Department in January 2020; and if he will make a statement on the matter. [57866/21]
View answerFollowing a tender by the Office of Government Procurement, Mazars conducted a review of the governance structures around the HSE's drug reimbursement process. The report was submitted to my Department in January 2020.
The review made recommendations in respect of the HSE’s systems, structures, processes, governance arrangements and use of specialist resources in respect of the drug reimbursement process.
The report was under consideration by officials, however the focus of the Department of Health changed to the immediate public health considerations of the COVID-19 pandemic and the preservation of life. This meant that this work stream was suspended to reallocate resources to support essential services.
My Department aims to complete its consideration of the report’s recommendations when resources permit.
